Puzo Michael J Abb Vie Inc. Transaction History

Puzo Michael J

$375 Million
Q3 2024

A detailed history of Puzo Michael J transactions in Abb Vie Inc. stock. As of the latest transaction made, Puzo Michael J holds 10,647 shares of ABBV stock, worth $1.87 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

10,647

Previous 10,764 1.09%

Holding current value

$1.87 Million

Previous $1.85 Million 13.87%

% of portfolio

0.56%

Previous 0.52%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $19,169 - $23,321	-117 Reduced 1.09%	10,647 $2.1 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $47,210 - $55,131	-305 Reduced 2.76%	10,764 $1.85 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $8,790 - $10,015	-55 Reduced 0.49%	11,069 $2.02 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $91,509 - $105,935	-685 Reduced 5.8%	11,124 $1.66 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $60,027 - $74,699	-453 Reduced 3.69%	11,809 $1.59 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $19,666 - $22,649	-136 Reduced 1.1%	12,262 $1.95 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $6,915 - $8,293	-50 Reduced 0.4%	12,398 $2 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $34,894 - $40,021	-260 Reduced 2.05%	12,448 $1.67 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $63,305 - $80,481	-460 Reduced 3.49%	12,708 $1.95 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $123,401 - $153,106	-935 Reduced 6.63%	13,168 $2.13 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $122,792 - $155,367	1,143 Added 8.82%	14,103 $1.91 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $22,876 - $25,967	-215 Reduced 1.63%	12,960 $1.4 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $315,630 - $351,630	-3,000 Reduced 18.55%	13,175 $1.48 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $23,017 - $25,339	225 Added 1.41%	16,175 $1.75 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $4,024 - $5,433	-50 Reduced 0.31%	15,950 $1.71 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $41,546 - $51,984	-576 Reduced 3.47%	16,000 $1.42 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $16,425 - $20,995	-250 Reduced 1.49%	16,576 $1.21 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $15,428 - $18,158	-200 Reduced 1.17%	16,826 $1.36 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $11,677 - $14,401	-150 Reduced 0.87%	17,026 $1.57 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $44,455 - $49,420	-500 Reduced 2.83%	17,176 $1.63 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $80,802 - $95,607	-900 Reduced 4.84%	17,676 $1.64 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $50,605 - $67,765	-550 Reduced 2.88%	18,576 $1.76 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $170,164 - $186,599	1,900 Added 11.03%	19,126 $1.85 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $1.2 Million - $1.54 Million	17,226	17,226 $1.53 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account